Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches
Amneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled ...
Read more
Tag: Autoinjector
Amneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled ...
Read more